Blueprint Medicines Corp (BPMC)
94.38
+1.38
(+1.48%)
USD |
NASDAQ |
Apr 29, 14:04
Blueprint Medicines Price: 94.38 for April 29, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 26, 2024 | 92.76 | 94.98 | 90.47 | 93.00 | 725494.0 |
Apr 25, 2024 | 89.54 | 91.46 | 88.46 | 90.73 | 755177.0 |
Apr 24, 2024 | 91.78 | 93.74 | 90.43 | 92.26 | 588540.0 |
Apr 23, 2024 | 90.48 | 94.67 | 89.19 | 92.29 | 788709.0 |
Apr 22, 2024 | 87.76 | 92.66 | 86.52 | 90.61 | 792073.0 |
Apr 19, 2024 | 88.45 | 89.90 | 84.62 | 86.85 | 813144.0 |
Apr 18, 2024 | 87.93 | 91.76 | 86.56 | 88.90 | 734936.0 |
Apr 17, 2024 | 87.31 | 89.69 | 86.76 | 88.38 | 728290.0 |
Apr 16, 2024 | 84.51 | 88.08 | 84.44 | 86.09 | 410709.0 |
Apr 15, 2024 | 87.18 | 87.84 | 84.33 | 85.18 | 506386.0 |
Apr 12, 2024 | 92.59 | 93.00 | 87.03 | 87.25 | 484715.0 |
Apr 11, 2024 | 91.47 | 92.56 | 90.44 | 92.25 | 404526.0 |
Apr 10, 2024 | 88.13 | 90.59 | 84.55 | 90.49 | 569839.0 |
Apr 09, 2024 | 92.27 | 93.93 | 91.34 | 92.20 | 710621.0 |
Apr 08, 2024 | 92.33 | 93.21 | 90.56 | 91.54 | 435421.0 |
Apr 05, 2024 | 90.00 | 91.76 | 88.23 | 91.65 | 485722.0 |
Apr 04, 2024 | 93.21 | 93.31 | 90.63 | 90.68 | 700458.0 |
Apr 03, 2024 | 90.42 | 93.36 | 90.31 | 92.23 | 583319.0 |
Apr 02, 2024 | 94.18 | 94.49 | 90.50 | 91.56 | 565099.0 |
Apr 01, 2024 | 95.00 | 97.00 | 93.70 | 96.42 | 604828.0 |
Mar 28, 2024 | 95.00 | 95.98 | 93.50 | 94.86 | 659240.0 |
Mar 27, 2024 | 90.08 | 94.91 | 89.12 | 94.79 | 796423.0 |
Mar 26, 2024 | 89.53 | 92.55 | 88.26 | 89.67 | 544645.0 |
Mar 25, 2024 | 87.59 | 89.58 | 86.76 | 88.22 | 337034.0 |
Mar 22, 2024 | 89.91 | 91.06 | 87.03 | 87.04 | 709076.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
37.97
Minimum
Feb 24 2023
124.48
Maximum
Dec 23 2020
74.93
Average
74.84
Median
Price Benchmarks
Alnylam Pharmaceuticals Inc | 148.08 |
Apellis Pharmaceuticals Inc | 48.39 |
Ionis Pharmaceuticals Inc | 42.15 |
Madrigal Pharmaceuticals Inc | 198.95 |
Sarepta Therapeutics Inc | 129.58 |
Price Related Metrics
PS Ratio | 22.92 |
Price to Book Value | 44.25 |
Earnings Yield | -8.86% |
Market Cap | 5.779B |